Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Cyclic GMP-AMP synthase inhibitors patented by BellBrook Labs

July 28, 2020

Sareum reports findings with TYK2/JAK1 inhibitors in disease model of lupus

July 24, 2020

RBM-007 enters phase I study for treatment of achondroplasia

July 16, 2020

First child dosed in phase II study of infigratinib in achondroplasia

July 16, 2020

New RIP-2 inhibitors discovered at Celgene

July 16, 2020

NMD Pharma cleared to begin phase I/IIa trial of NMD-670 for myasthenia gravis

July 15, 2020

FDA approves Tremfya for active psoriatic arthritis

July 15, 2020

FDA approves IND for phase I/IIa study of FCR-001 for diffuse systemic sclerosis

July 9, 2020

Good vs. evil in the synovial joint

July 8, 2020

Lilly patents TYK2 JH2 domain ligands

July 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...